Media Partners
CAMBRIDGE, Mass., April 25, 2023 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has approved QALSODY™ (tofersen) 100 mg/15mL injection for…
NurOwn (BrainStorm Cell Therapeutics) is an investigational therapy made up of autologous mesenchymal stromal cells secreting neurotrophic factors cells (MSC-NTF) for the potential treatment of amyotrophic lateral sclerosis (ALS) and…
Cytokinetics recently announced the discontinuation of Phase 3 Clinical Trial of Reldesemtiv and thanks the people with ALS, caregivers, investigators, and clinical trial staff for their participation in COURAGE-ALS.
East Bay theater director Erin Merritt is living with the debilitating effects of ALS, the degenerative nervous system disorder also known as Lou Gehrig’s Disease. Even though she struggles to…
Erin Merritt has been a powerful force in Bay Area theater for decades, as a director, actor, producer and as someone who all-around makes things happen. Founder of the all-female…
A year ago, Erin Merritt stopped being able to sing in tune during her car karaoke. Then the El Cerrito director, who has been working in Bay Area theater for…
Neurodegenerative diseases can damage different parts of the nervous system, including the brain. This may lead to problems with thinking, memory, and/or movement. Examples include Alzheimer’s disease (AD), multiple sclerosis…
Neurology fellow finds diagnostic delays in Black ALS patients prevents life-altering therapies. It was only his first visit to a hospital’s ALS clinic, but already the Black patient’s amyotrophic lateral…
Each year in the U.S., 5,000 patients receive a diagnosis of ALS, an incurable neurodegenerative disease that will likely kill them within two to five years. In the quest to…
- 1
- 2
- Siguiente »